Karen Bohmwald
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Karen Bohmwald has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
- Alexis M. Kalergis
Millennium Institute on Immunology and Immunotherapy, Santiago, Chile
9 shared publications - Jorge Soto-Delgado
Departamento de Ciencias Químicas, Facultad de Ciencias Exactas Bello, Universidad Andrés Bello, Quillota 980, Viña del Mar 2531015, Chile
4 shared publications - Catalina A. Andrade
Millennium Institute of Immunology and Immunotherapy, Departamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago 8331150, Chile
3 shared publications - Anirban Ghosh
Cell Development and Immunobiology Laboratory, Department of Zoology, Netaji Subhas Open University, Kolkata, India, India
2 shared publications - Felipe R. Uribe
Millennium Institute on Immunology and Immunotherapy, Laboratorio de Inmunología Traslacional, Departamento de Ciencias Biológicas, Facultad de Ciencias de la Vida, Universidad Andrés Bello, Santiago 8370133, Chile
2 shared publications - Pablo A. Gonzalez
Millennium Institute on Immunology and Immunotherapy, Santiago, Chile
2 shared publications
Latest Publications
- Open Access
- 26 October 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1891967
MHC-II+ G-MDSC expressing CD80, CD86, or ICOSL are associated with pro-inflammatory CD4+ T cells phenotypes in the lungs of lupus-prone mice
Systemic lupus erythematosus (SLE) is a chronic inflammatory autoimmune disease that affects various tissues of the body. One of these tissues is the lung, in which pleuropulmonary manifestations commonly occur. In these patients, homeostasis is disrupted, characterized by a decrease in T reg and an increase in T h1 and T h2 cells. Myeloid-derived suppressor cells (MDSCs) are a cell population characterized by their ability to suppress the T cell response; however, in recent years, the presence of major histocompatibility complex class II (MHC-II) molecules on MDSCs has been reported. Nevertheless, the presence of costimulatory molecules, such as CD80, CD86, and ICOSL, has not been studied yet in MDSCs expressing MHC-II in the context of SLE. In this study, we evaluated the pulmonary microenvironment in SLE mice from an immunological and histological perspective. We observed increased pro-inflammatory cytokines and cellular infiltration in lungs of SLE mice. We also observed MDSC MHC-II cells expressing CD80, CD86, and ICOSL in this tissue, along with alterations of CD4 + T cells subsets, characterized by a decrease in IL-10 frequency in SLE mice. Moreover, we observed that G-MDSCs MHC-II expressing CD80, CD86, or ICOSL correlate positively with phenotypes of CD4 + T cells that produce IL-17 and IFN-γ. For this reason, we suggest that MHC-II + G-MDSC cells may contribute to an inflammatory environment that triggers tissue damage in the lungs of SLE mice.
- 26 October 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1891967
Open AccessMHC-II+ G-MDSC expressing CD80, CD86, or ICOSL are associated with pro-inflammatory CD4+ T cells phenotypes in the lungs of lupus-prone mice
Systemic lupus erythematosus (SLE) is a chronic inflammatory autoimmune disease that affects various tissues of the body. One of these tissues is the lung, in which pleuropulmonary manifestations commonly occur. In these patients, homeostasis is disrupted, characterized by a decrease in T reg and an increase in T h1 and T h2 cells. Myeloid-derived suppressor cells (MDSCs) are a cell population characterized by their ability to suppress the T cell response; however, in recent years, the presence of major histocompatibility complex class II (MHC-II) molecules on MDSCs has been reported. Nevertheless, the presence of costimulatory molecules, such as CD80, CD86, and ICOSL, has not been studied yet in MDSCs expressing MHC-II in the context of SLE. In this study, we evaluated the pulmonary microenvironment in SLE mice from an immunological and histological perspective. We observed increased pro-inflammatory cytokines and cellular infiltration in lungs of SLE mice. We also observed MDSC MHC-II cells expressing CD80, CD86, and ICOSL in this tissue, along with alterations of CD4 + T cells subsets, characterized by a decrease in IL-10 frequency in SLE mice. Moreover, we observed that G-MDSCs MHC-II expressing CD80, CD86, or ICOSL correlate positively with phenotypes of CD4 + T cells that produce IL-17 and IFN-γ. For this reason, we suggest that MHC-II + G-MDSC cells may contribute to an inflammatory environment that triggers tissue damage in the lungs of SLE mice.
- Open Access
- 16 September 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1972861
Correction: Editorial: CNS immunity – paradox of maintenance, repair and destruction
Selective gateways for antigen exchange, immune cell trafficking, and bidirectional signaling. Pathways via the olfactory and vagus nerves, coupled with neuroendocrine axes, further integrate CNS immunity with systemic physiology. The gut-brain axis, mediated by microbiota-derived metabolites and immune signaling, exemplifies this systemic interconnection, linking peripheral inflammation to neurodegeneration and psychiatric disorders (Cryan et al., 2019). Thus, CNS immunity is no longer confined to the parenchyma but embedded within a broader neuro-immune-endocrine-microbiota network, where repair and destruction coexist in delicate balance.Modern neuroimmunology now thrives at the intersection of molecular biology, neuroimaging, and computational systems science. High-throughput platforms-single-cell and spatial RNA-seq, proteomics, and metabolomics-map cellular diversity with unprecedented resolution, while advanced neuroimaging modalities (CT, MRI, and PET) integrate structural and functional data. Machine learning and AI-driven analytics synthesize these datasets, enabling predictive modeling of disease trajectories and therapeutic responses (Ebrahimkhani et al., 2020). Systems biology approaches reveal evolutionary interrelations of CNS immunity, situating human brain disorders within a continuum of adaptive and maladaptive immune responses. This transformation-from microglial discovery to systemic integration-revealed the paradox at the heart of CNS immunity: mechanisms that maintain homeostasis and enable repair can, under chronic dysregulation, drive destruction. On the one hand, microglia were identified as protective in the case of Amyloid-beta phagocytosing disease-associated microglia (MGnD or DAM) (Krasemann et al, 2017, Keren-Shaul et al 2017). On the other hand, as maladaptive tumor-associated macrophages microglia are involved in glioblastoma-associated immune suppression and mortality (Miller et al 2025). These studies exemplify how the niche determines divergent functional immune states.The present volume exemplifies the breadth of modern neuroimmunology, moving from cellular and molecular mechanisms to systemic integration. It captures the paradoxical nature of CNS immunitywhere the same processes that maintain homeostasis and enable repair can, under chronic dysregulation, drive destruction. Cross-disciplinary perspectives linking neuroimmunity with vascular biology, tumor immunology, microbiota, and neuroendocrine signaling in this collection of papers demonstrate that CNS immunity is no longer isolation but as part of a dynamic neuroimmune-endocrine-microbiota network.Cavalcanti et al., in their review "Neuroinflammation: targeting microglia for neuroprotection and repair after spinal cord injury," dissect the paradoxical role of microglia in SCI, where they showed how early activation clears debris and supports axonal growth, but chronic signaling unleashes TNF-α, IL-1β, and IL-6, driving secondary injury and BBB breakdown. Using information gathered from the literature, they reveal microglial phenotypes as a dynamic continuum rather than binary M1/M2 states. The review highlights translational strategies-small molecules, biologics, exosomes, and BBB stabilizers-to reprogram microglia toward repair. The punchline is that microglia are both protectors and perpetrators, and precision modulation is key to meaningful recovery.Preeclampsia is a multisystem hypertensive disorder of pregnancy in which defective trophoblast invasion and placental ischemia initiate a cascade of anti-angiogenic and pro-inflammatory signals that extend beyond the maternal-fetal interface. Interestingly, Jingting Liu et al. redefine preeclampsia as a neuro-immune-vascular disorder in their review "The neuro-immune axis in preeclampsia: from the maternal-fetal interface to systemic dysregulation," moving beyond placental angiogenic imbalance to highlight dysfunctional crosstalk between neural circuits, immune cells, and vascular tone. They show how sympathetic overactivity, vagal dysregulation, and neuropeptide signaling amplify placental hypoxia, endothelial injury, and systemic inflammation. Using single-cell and spatial omics, the review uncovers aberrant dNK, macrophage, and Treg phenotypes at the maternal-fetal interface, as well as neuro-immune modulation in the bone marrow and spleen. Critically, CNS inflammation and BBB disruption emerge as drivers of seizures and long-term cerebrovascular risk. They conveyed the message that PE is sustained by feed-forward neuro-immune loops, demanding biomarker-guided neuro-modulatory therapies. Anirban Ghosh edits both of these papers.The global crisis of antimicrobial resistance highlights the critical need for host-directed therapies that augment, rather than supplant, conventional antibiotics (Kaufmann et al., 2018;World Health Organization, 2015). Present study by Seele et al. ( 2026) in the volume edited by Sagar Acharya establishes that glatiramer acetate (GA)-a synthetic polypeptide safely utilized for over twenty years to treat relapsing-remitting multiple sclerosis (MS) (Aharoni, 2013;Arnon and Aharoni, 2004)-acts as a potent enhancer of innate immunity. The investigators demonstrate that GA significantly accelerates the phagocytosis and intracellular killing of encapsulated Escherichia coli K1 by primary macrophages and microglial cells.Mechanistically, this immunostimulatory effect depends fundamentally on the interleukin-10 (IL-10) pathway. While IL-10 is traditionally viewed as an anti-inflammatory suppressor of immunity (Saraiva and O'Garra, 2010), this study challenges that dogma. Antibody-mediated neutralization of IL-10 partially blocked GA-induced microglial phagocytosis, while ex vivo evaluations confirmed that in vivo GA pretreatment successfully primed macrophages from wild-type mice but completely failed in strains. This underscores the highly complex regulatory role of cytokine networks in host defense (Couper et...
- 16 September 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1972861
Open AccessCorrection: Editorial: CNS immunity – paradox of maintenance, repair and destruction
Selective gateways for antigen exchange, immune cell trafficking, and bidirectional signaling. Pathways via the olfactory and vagus nerves, coupled with neuroendocrine axes, further integrate CNS immunity with systemic physiology. The gut-brain axis, mediated by microbiota-derived metabolites and immune signaling, exemplifies this systemic interconnection, linking peripheral inflammation to neurodegeneration and psychiatric disorders (Cryan et al., 2019). Thus, CNS immunity is no longer confined to the parenchyma but embedded within a broader neuro-immune-endocrine-microbiota network, where repair and destruction coexist in delicate balance.Modern neuroimmunology now thrives at the intersection of molecular biology, neuroimaging, and computational systems science. High-throughput platforms-single-cell and spatial RNA-seq, proteomics, and metabolomics-map cellular diversity with unprecedented resolution, while advanced neuroimaging modalities (CT, MRI, and PET) integrate structural and functional data. Machine learning and AI-driven analytics synthesize these datasets, enabling predictive modeling of disease trajectories and therapeutic responses (Ebrahimkhani et al., 2020). Systems biology approaches reveal evolutionary interrelations of CNS immunity, situating human brain disorders within a continuum of adaptive and maladaptive immune responses. This transformation-from microglial discovery to systemic integration-revealed the paradox at the heart of CNS immunity: mechanisms that maintain homeostasis and enable repair can, under chronic dysregulation, drive destruction. On the one hand, microglia were identified as protective in the case of Amyloid-beta phagocytosing disease-associated microglia (MGnD or DAM) (Krasemann et al, 2017, Keren-Shaul et al 2017). On the other hand, as maladaptive tumor-associated macrophages microglia are involved in glioblastoma-associated immune suppression and mortality (Miller et al 2025). These studies exemplify how the niche determines divergent functional immune states.The present volume exemplifies the breadth of modern neuroimmunology, moving from cellular and molecular mechanisms to systemic integration. It captures the paradoxical nature of CNS immunitywhere the same processes that maintain homeostasis and enable repair can, under chronic dysregulation, drive destruction. Cross-disciplinary perspectives linking neuroimmunity with vascular biology, tumor immunology, microbiota, and neuroendocrine signaling in this collection of papers demonstrate that CNS immunity is no longer isolation but as part of a dynamic neuroimmune-endocrine-microbiota network.Cavalcanti et al., in their review "Neuroinflammation: targeting microglia for neuroprotection and repair after spinal cord injury," dissect the paradoxical role of microglia in SCI, where they showed how early activation clears debris and supports axonal growth, but chronic signaling unleashes TNF-α, IL-1β, and IL-6, driving secondary injury and BBB breakdown. Using information gathered from the literature, they reveal microglial phenotypes as a dynamic continuum rather than binary M1/M2 states. The review highlights translational strategies-small molecules, biologics, exosomes, and BBB stabilizers-to reprogram microglia toward repair. The punchline is that microglia are both protectors and perpetrators, and precision modulation is key to meaningful recovery.Preeclampsia is a multisystem hypertensive disorder of pregnancy in which defective trophoblast invasion and placental ischemia initiate a cascade of anti-angiogenic and pro-inflammatory signals that extend beyond the maternal-fetal interface. Interestingly, Jingting Liu et al. redefine preeclampsia as a neuro-immune-vascular disorder in their review "The neuro-immune axis in preeclampsia: from the maternal-fetal interface to systemic dysregulation," moving beyond placental angiogenic imbalance to highlight dysfunctional crosstalk between neural circuits, immune cells, and vascular tone. They show how sympathetic overactivity, vagal dysregulation, and neuropeptide signaling amplify placental hypoxia, endothelial injury, and systemic inflammation. Using single-cell and spatial omics, the review uncovers aberrant dNK, macrophage, and Treg phenotypes at the maternal-fetal interface, as well as neuro-immune modulation in the bone marrow and spleen. Critically, CNS inflammation and BBB disruption emerge as drivers of seizures and long-term cerebrovascular risk. They conveyed the message that PE is sustained by feed-forward neuro-immune loops, demanding biomarker-guided neuro-modulatory therapies. Anirban Ghosh edits both of these papers.The global crisis of antimicrobial resistance highlights the critical need for host-directed therapies that augment, rather than supplant, conventional antibiotics (Kaufmann et al., 2018;World Health Organization, 2015). Present study by Seele et al. ( 2026) in the volume edited by Sagar Acharya establishes that glatiramer acetate (GA)-a synthetic polypeptide safely utilized for over twenty years to treat relapsing-remitting multiple sclerosis (MS) (Aharoni, 2013;Arnon and Aharoni, 2004)-acts as a potent enhancer of innate immunity. The investigators demonstrate that GA significantly accelerates the phagocytosis and intracellular killing of encapsulated Escherichia coli K1 by primary macrophages and microglial cells.Mechanistically, this immunostimulatory effect depends fundamentally on the interleukin-10 (IL-10) pathway. While IL-10 is traditionally viewed as an anti-inflammatory suppressor of immunity (Saraiva and O'Garra, 2010), this study challenges that dogma. Antibody-mediated neutralization of IL-10 partially blocked GA-induced microglial phagocytosis, while ex vivo evaluations confirmed that in vivo GA pretreatment successfully primed macrophages from wild-type mice but completely failed in strains. This underscores the highly complex regulatory role of cytokine networks in host defense (Couper et...
- Open Access
- 18 August 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1954884
Editorial: CNS immunity – paradox of maintenance, repair and destruction
Selective gateways for antigen exchange, immune cell trafficking, and bidirectional signaling. Pathways via the olfactory and vagus nerves, coupled with neuroendocrine axes, further integrate CNS immunity with systemic physiology. The gut-brain axis, mediated by microbiota-derived metabolites and immune signaling, exemplifies this systemic interconnection, linking peripheral inflammation to neurodegeneration and psychiatric disorders (Cryan et al., 2019). Thus, CNS immunity is no longer confined to the parenchyma but embedded within a broader neuro-immune-endocrine-microbiota network, where repair and destruction coexist in delicate balance.Modern neuroimmunology now thrives at the intersection of molecular biology, neuroimaging, and computational systems science. High-throughput platforms-single-cell and spatial RNA-seq, proteomics, and metabolomics-map cellular diversity with unprecedented resolution, while advanced neuroimaging modalities (CT, MRI, and PET) integrate structural and functional data. Machine learning and AI-driven analytics synthesize these datasets, enabling predictive modeling of disease trajectories and therapeutic responses (Ebrahimkhani et al., 2020). Systems biology approaches reveal evolutionary interrelations of CNS immunity, situating human brain disorders within a continuum of adaptive and maladaptive immune responses. This transformation-from microglial discovery to systemic integration-revealed the paradox at the heart of CNS immunity: mechanisms that maintain homeostasis and enable repair can, under chronic dysregulation, drive destruction. On the one hand, icroglia were identified as protective in the case of Amyloid-beta phagocytosing disease-associated microglia (MGnD or DAM) (Krasemann et al, 2017, Keren-Shaul et al 2017). On the other hand, as maladaptive tumor-associated macrophages microglia are involved in glioblastoma-associated immune suppression and mortality (Miller et al 2025). These studies exemplify how the niche determines divergent functional immune states.The present volume exemplifies the breadth of modern neuroimmunology, moving from cellular and molecular mechanisms to systemic integration. It captures the paradoxical nature of CNS immunitywhere the same processes that maintain homeostasis and enable repair can, under chronic dysregulation, drive destruction. Cross-disciplinary perspectives linking neuroimmunity with vascular biology, tumor immunology, microbiota, and neuroendocrine signaling in this collection of papers demonstrate that CNS immunity is no longer viewed in isolation but as part of a dynamic neuroimmune-endocrine-microbiota network.Cavalcanti et al., in their review "Neuroinflammation: targeting microglia for neuroprotection and repair after spinal cord injury," dissect the paradoxical role of microglia in SCI, where they showed how early activation clears debris and supports axonal growth, but chronic signaling unleashes TNF-α, IL-1β, and IL-6, driving secondary injury and BBB breakdown. Using information gathered from the literature, they reveal microglial phenotypes as a dynamic continuum rather than binary M1/M2 states. The review highlights translational strategies-small molecules, biologics, exosomes, and BBB stabilizers-to reprogram microglia toward repair. The punchline is that microglia are both protectors and perpetrators, and precision modulation is key to meaningful recovery.Preeclampsia is a multisystem hypertensive disorder of pregnancy in which defective trophoblast invasion and placental ischemia initiate a cascade of anti-angiogenic and pro-inflammatory signals that extend beyond the maternal-fetal interface. Interestingly, Jingting Liu et al. redefine preeclampsia as a neuro-immune-vascular disorder in their review "The neuro-immune axis in preeclampsia: from the maternal-fetal interface to systemic dysregulation," moving beyond placental angiogenic imbalance to highlight dysfunctional crosstalk between neural circuits, immune cells, and vascular tone. They show how sympathetic overactivity, vagal dysregulation, and neuropeptide signaling amplify placental hypoxia, endothelial injury, and systemic inflammation. Using single-cell and spatial omics, the review uncovers aberrant dNK, macrophage, and Treg phenotypes at the maternal-fetal interface, as well as neuro-immune modulation in the bone marrow and spleen. Critically, CNS inflammation and BBB disruption emerge as drivers of seizures and long-term cerebrovascular risk. They conveyed the message that PE is sustained by feed-forward neuro-immune loops, demanding biomarker-guided neuro-modulatory therapies. Anirban Ghosh edits both of these papers.The global crisis of antimicrobial resistance highlights the critical need for host-directed therapies that augment, rather than supplant, conventional antibiotics (Kaufmann et al., 2018;World Health Organization, 2015). Present study by Seele et al. ( 2026) in the volume edited by Sagar Acharya establishes that glatiramer acetate (GA)-a synthetic polypeptide safely utilized for over twenty years to treat relapsing-remitting multiple sclerosis (MS) (Aharoni, 2013;Arnon and Aharoni, 2004)-acts as a potent enhancer of innate immunity. The investigators demonstrate that GA significantly accelerates the phagocytosis and intracellular killing of encapsulated Escherichia coli K1 by primary macrophages and microglial cells.Mechanistically, this immunostimulatory effect depends fundamentally on the interleukin-10 (IL-10) pathway. While IL-10 is traditionally viewed as an anti-inflammatory suppressor of immunity (Saraiva and O'Garra, 2010), this study challenges that dogma. Antibody-mediated neutralization of IL-10 partially blocked GA-induced microglial phagocytosis, while ex vivo evaluations confirmed that in vivo GA pretreatment successfully primed macrophages from wild-type mice but completely failed in strains. This underscores the highly complex regulatory role of cytokine networks in host defense...
- 18 August 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1954884
Open AccessEditorial: CNS immunity – paradox of maintenance, repair and destruction
Selective gateways for antigen exchange, immune cell trafficking, and bidirectional signaling. Pathways via the olfactory and vagus nerves, coupled with neuroendocrine axes, further integrate CNS immunity with systemic physiology. The gut-brain axis, mediated by microbiota-derived metabolites and immune signaling, exemplifies this systemic interconnection, linking peripheral inflammation to neurodegeneration and psychiatric disorders (Cryan et al., 2019). Thus, CNS immunity is no longer confined to the parenchyma but embedded within a broader neuro-immune-endocrine-microbiota network, where repair and destruction coexist in delicate balance.Modern neuroimmunology now thrives at the intersection of molecular biology, neuroimaging, and computational systems science. High-throughput platforms-single-cell and spatial RNA-seq, proteomics, and metabolomics-map cellular diversity with unprecedented resolution, while advanced neuroimaging modalities (CT, MRI, and PET) integrate structural and functional data. Machine learning and AI-driven analytics synthesize these datasets, enabling predictive modeling of disease trajectories and therapeutic responses (Ebrahimkhani et al., 2020). Systems biology approaches reveal evolutionary interrelations of CNS immunity, situating human brain disorders within a continuum of adaptive and maladaptive immune responses. This transformation-from microglial discovery to systemic integration-revealed the paradox at the heart of CNS immunity: mechanisms that maintain homeostasis and enable repair can, under chronic dysregulation, drive destruction. On the one hand, icroglia were identified as protective in the case of Amyloid-beta phagocytosing disease-associated microglia (MGnD or DAM) (Krasemann et al, 2017, Keren-Shaul et al 2017). On the other hand, as maladaptive tumor-associated macrophages microglia are involved in glioblastoma-associated immune suppression and mortality (Miller et al 2025). These studies exemplify how the niche determines divergent functional immune states.The present volume exemplifies the breadth of modern neuroimmunology, moving from cellular and molecular mechanisms to systemic integration. It captures the paradoxical nature of CNS immunitywhere the same processes that maintain homeostasis and enable repair can, under chronic dysregulation, drive destruction. Cross-disciplinary perspectives linking neuroimmunity with vascular biology, tumor immunology, microbiota, and neuroendocrine signaling in this collection of papers demonstrate that CNS immunity is no longer viewed in isolation but as part of a dynamic neuroimmune-endocrine-microbiota network.Cavalcanti et al., in their review "Neuroinflammation: targeting microglia for neuroprotection and repair after spinal cord injury," dissect the paradoxical role of microglia in SCI, where they showed how early activation clears debris and supports axonal growth, but chronic signaling unleashes TNF-α, IL-1β, and IL-6, driving secondary injury and BBB breakdown. Using information gathered from the literature, they reveal microglial phenotypes as a dynamic continuum rather than binary M1/M2 states. The review highlights translational strategies-small molecules, biologics, exosomes, and BBB stabilizers-to reprogram microglia toward repair. The punchline is that microglia are both protectors and perpetrators, and precision modulation is key to meaningful recovery.Preeclampsia is a multisystem hypertensive disorder of pregnancy in which defective trophoblast invasion and placental ischemia initiate a cascade of anti-angiogenic and pro-inflammatory signals that extend beyond the maternal-fetal interface. Interestingly, Jingting Liu et al. redefine preeclampsia as a neuro-immune-vascular disorder in their review "The neuro-immune axis in preeclampsia: from the maternal-fetal interface to systemic dysregulation," moving beyond placental angiogenic imbalance to highlight dysfunctional crosstalk between neural circuits, immune cells, and vascular tone. They show how sympathetic overactivity, vagal dysregulation, and neuropeptide signaling amplify placental hypoxia, endothelial injury, and systemic inflammation. Using single-cell and spatial omics, the review uncovers aberrant dNK, macrophage, and Treg phenotypes at the maternal-fetal interface, as well as neuro-immune modulation in the bone marrow and spleen. Critically, CNS inflammation and BBB disruption emerge as drivers of seizures and long-term cerebrovascular risk. They conveyed the message that PE is sustained by feed-forward neuro-immune loops, demanding biomarker-guided neuro-modulatory therapies. Anirban Ghosh edits both of these papers.The global crisis of antimicrobial resistance highlights the critical need for host-directed therapies that augment, rather than supplant, conventional antibiotics (Kaufmann et al., 2018;World Health Organization, 2015). Present study by Seele et al. ( 2026) in the volume edited by Sagar Acharya establishes that glatiramer acetate (GA)-a synthetic polypeptide safely utilized for over twenty years to treat relapsing-remitting multiple sclerosis (MS) (Aharoni, 2013;Arnon and Aharoni, 2004)-acts as a potent enhancer of innate immunity. The investigators demonstrate that GA significantly accelerates the phagocytosis and intracellular killing of encapsulated Escherichia coli K1 by primary macrophages and microglial cells.Mechanistically, this immunostimulatory effect depends fundamentally on the interleukin-10 (IL-10) pathway. While IL-10 is traditionally viewed as an anti-inflammatory suppressor of immunity (Saraiva and O'Garra, 2010), this study challenges that dogma. Antibody-mediated neutralization of IL-10 partially blocked GA-induced microglial phagocytosis, while ex vivo evaluations confirmed that in vivo GA pretreatment successfully primed macrophages from wild-type mice but completely failed in strains. This underscores the highly complex regulatory role of cytokine networks in host defense...
- Open Access
- 23 February 2026
- Published by Qeios Ltd
Review of: "Infectious vs. Sterile Neuroinflammation: Differential Consequences on Neuronal Circuitry"
The manuscript presents an extensive narrative review addressing the impact of neuroinflammation on neuronal circuit function, with a central emphasis on temporality, persistence, and resolution as primary determinants of functional outcomes. The top...
- 23 February 2026
- Published by Qeios Ltd
Open AccessReview of: "Infectious vs. Sterile Neuroinflammation: Differential Consequences on Neuronal Circuitry"
The manuscript presents an extensive narrative review addressing the impact of neuroinflammation on neuronal circuit function, with a central emphasis on temporality, persistence, and resolution as primary determinants of functional outcomes. The top...
- Open Access
- 19 December 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (24) , 13604
Characterization of Dendritic Cells and Myeloid-Derived Suppressor Cells Expressing Major Histocompatibility Complex Class II in Secondary Lymphoid Organs in Systemic Lupus Erythematosus-Prone Mice
Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by self-antibody production and widespread inflammation affecting various body tissues. This disease is driven by the breakdown of immune tolerance, which promotes the activation of autoreactive B and T cells. A key feature of SLE is dysregulation in antigen presentation, where antigen-presenting cells (APCs) play a central role in perpetuating immune responses. Dendritic cells (DCs) are highly specialized for antigen presentation among APCs. At the same time, myeloid-derived suppressor cells (MDSCs) can also express MHC-II molecules, although their role in SLE is less understood. Utilizing the SLE model, MRL/MpJ-Faslpr/J, we determined the presence of different phenotypes of DCs and MDSCs expressing MHC-II in secondary lymphoid organs, along with the gene expression of ICOSL, CD80 and CD86 in the spleen. Our study determined that the most abundant population of APCs in secondary lymphoid organs corresponds to cDC CD103−CD11b+ MHC-II+ throughout SLE development. Additionally, ICOSL expression increased over time, becoming more preponderant in week 16 in the SLE model, which could indicate that it is a crucial pathway for the development and progression of the pathology. In week 16, we observed a positive correlation between M-MDSC MHC-II and IFN-γ-producing CD4+ T cells.
- 19 December 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (24) , 13604
Open AccessCharacterization of Dendritic Cells and Myeloid-Derived Suppressor Cells Expressing Major Histocompatibility Complex Class II in Secondary Lymphoid Organs in Systemic Lupus Erythematosus-Prone Mice
Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by self-antibody production and widespread inflammation affecting various body tissues. This disease is driven by the breakdown of immune tolerance, which promotes the activation of autoreactive B and T cells. A key feature of SLE is dysregulation in antigen presentation, where antigen-presenting cells (APCs) play a central role in perpetuating immune responses. Dendritic cells (DCs) are highly specialized for antigen presentation among APCs. At the same time, myeloid-derived suppressor cells (MDSCs) can also express MHC-II molecules, although their role in SLE is less understood. Utilizing the SLE model, MRL/MpJ-Faslpr/J, we determined the presence of different phenotypes of DCs and MDSCs expressing MHC-II in secondary lymphoid organs, along with the gene expression of ICOSL, CD80 and CD86 in the spleen. Our study determined that the most abundant population of APCs in secondary lymphoid organs corresponds to cDC CD103−CD11b+ MHC-II+ throughout SLE development. Additionally, ICOSL expression increased over time, becoming more preponderant in week 16 in the SLE model, which could indicate that it is a crucial pathway for the development and progression of the pathology. In week 16, we observed a positive correlation between M-MDSC MHC-II and IFN-γ-producing CD4+ T cells.
- Open Access
- 20 August 2024
- Published by MDPI AG in Microorganisms
- Vol. 12 (8) , 1713
Neurological Impact of Respiratory Viruses: Insights into Glial Cell Responses in the Central Nervous System
Respiratory viral infections pose a significant public health threat, particularly in children and older adults, with high mortality rates. Some of these pathogens are the human respiratory syncytial virus (hRSV), severe acute respiratory coronavirus-2 (SARS-CoV-2), influenza viruses (IV), human parvovirus B19 (B19V), and human bocavirus 1 (HBoV1). These viruses cause various respiratory symptoms, including cough, fever, bronchiolitis, and pneumonia. Notably, these viruses can also impact the central nervous system (CNS), leading to acute manifestations such as seizures, encephalopathies, encephalitis, neurological sequelae, and long-term complications. The precise mechanisms by which these viruses affect the CNS are not fully understood. Glial cells, specifically microglia and astrocytes within the CNS, play pivotal roles in maintaining brain homeostasis and regulating immune responses. Exploring how these cells interact with viral pathogens, such as hRSV, SARS-CoV-2, IVs, B19V, and HBoV1, offers crucial insights into the significant impact of respiratory viruses on the CNS. This review article examines hRSV, SARS-CoV-2, IV, B19V, and HBoV1 interactions with microglia and astrocytes, shedding light on potential neurological consequences.
- 20 August 2024
- Published by MDPI AG in Microorganisms
- Vol. 12 (8) , 1713
Open AccessNeurological Impact of Respiratory Viruses: Insights into Glial Cell Responses in the Central Nervous System
Respiratory viral infections pose a significant public health threat, particularly in children and older adults, with high mortality rates. Some of these pathogens are the human respiratory syncytial virus (hRSV), severe acute respiratory coronavirus-2 (SARS-CoV-2), influenza viruses (IV), human parvovirus B19 (B19V), and human bocavirus 1 (HBoV1). These viruses cause various respiratory symptoms, including cough, fever, bronchiolitis, and pneumonia. Notably, these viruses can also impact the central nervous system (CNS), leading to acute manifestations such as seizures, encephalopathies, encephalitis, neurological sequelae, and long-term complications. The precise mechanisms by which these viruses affect the CNS are not fully understood. Glial cells, specifically microglia and astrocytes within the CNS, play pivotal roles in maintaining brain homeostasis and regulating immune responses. Exploring how these cells interact with viral pathogens, such as hRSV, SARS-CoV-2, IVs, B19V, and HBoV1, offers crucial insights into the significant impact of respiratory viruses on the CNS. This review article examines hRSV, SARS-CoV-2, IV, B19V, and HBoV1 interactions with microglia and astrocytes, shedding light on potential neurological consequences.
- Open Access
- 6 January 2024
- Published by MDPI AG in Brain Sciences
- Vol. 14 (1) , 59
Understanding the Neurotrophic Virus Mechanisms and Their Potential Effect on Systemic Lupus Erythematosus Development
Central nervous system (CNS) pathologies are a public health concern, with viral infections one of their principal causes. These viruses are known as neurotropic pathogens, characterized by their ability to infiltrate the CNS and thus interact with various cell populations, inducing several diseases. The immune response elicited by neurotropic viruses in the CNS is commanded mainly by microglia, which, together with other local cells, can secrete inflammatory cytokines to fight the infection. The most relevant neurotropic viruses are adenovirus (AdV), cytomegalovirus (CMV), enterovirus (EV), Epstein–Barr Virus (EBV), herpes simplex virus type 1 (HSV-1), and herpes simplex virus type 2 (HSV-2), lymphocytic choriomeningitis virus (LCMV), and the newly discovered SARS-CoV-2. Several studies have associated a viral infection with systemic lupus erythematosus (SLE) and neuropsychiatric lupus (NPSLE) manifestations. This article will review the knowledge about viral infections, CNS pathologies, and the immune response against them. Also, it allows us to understand the relevance of the different viral proteins in developing neuronal pathologies, SLE and NPSLE.
- 6 January 2024
- Published by MDPI AG in Brain Sciences
- Vol. 14 (1) , 59
Open AccessUnderstanding the Neurotrophic Virus Mechanisms and Their Potential Effect on Systemic Lupus Erythematosus Development
Central nervous system (CNS) pathologies are a public health concern, with viral infections one of their principal causes. These viruses are known as neurotropic pathogens, characterized by their ability to infiltrate the CNS and thus interact with various cell populations, inducing several diseases. The immune response elicited by neurotropic viruses in the CNS is commanded mainly by microglia, which, together with other local cells, can secrete inflammatory cytokines to fight the infection. The most relevant neurotropic viruses are adenovirus (AdV), cytomegalovirus (CMV), enterovirus (EV), Epstein–Barr Virus (EBV), herpes simplex virus type 1 (HSV-1), and herpes simplex virus type 2 (HSV-2), lymphocytic choriomeningitis virus (LCMV), and the newly discovered SARS-CoV-2. Several studies have associated a viral infection with systemic lupus erythematosus (SLE) and neuropsychiatric lupus (NPSLE) manifestations. This article will review the knowledge about viral infections, CNS pathologies, and the immune response against them. Also, it allows us to understand the relevance of the different viral proteins in developing neuronal pathologies, SLE and NPSLE.
- Open Access
- 22 May 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (10) , 5817
Neurotrophin Signaling Impairment by Viral Infections in the Central Nervous System
Neurotrophins, such as nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), and neurotrophin 3 (NT-3), NT-4, and NT-5, are proteins involved in several important functions of the central nervous system. The activation of the signaling pathways of these neurotrophins, or even by their immature form, pro-neurotrophins, starts with their recognition by cellular receptors, such as tropomyosin receptor kinase (Trk) and 75 kD NT receptors (p75NTR). The Trk receptor is considered to have a high affinity for attachment to specific neurotrophins, while the p75NTR receptor has less affinity for attachment with neurotrophins. The correct functioning of these signaling pathways contributes to proper brain development, neuronal survival, and synaptic plasticity. Unbalanced levels of neurotrophins and pro-neurotrophins have been associated with neurological disorders, illustrating the importance of these molecules in the central nervous system. Furthermore, reports have indicated that viruses can alter the normal levels of neurotrophins by interfering with their signaling pathways. This work discusses the importance of neurotrophins in the central nervous system, their signaling pathways, and how viruses can affect them.
- 22 May 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (10) , 5817
Open AccessNeurotrophin Signaling Impairment by Viral Infections in the Central Nervous System
Neurotrophins, such as nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), and neurotrophin 3 (NT-3), NT-4, and NT-5, are proteins involved in several important functions of the central nervous system. The activation of the signaling pathways of these neurotrophins, or even by their immature form, pro-neurotrophins, starts with their recognition by cellular receptors, such as tropomyosin receptor kinase (Trk) and 75 kD NT receptors (p75NTR). The Trk receptor is considered to have a high affinity for attachment to specific neurotrophins, while the p75NTR receptor has less affinity for attachment with neurotrophins. The correct functioning of these signaling pathways contributes to proper brain development, neuronal survival, and synaptic plasticity. Unbalanced levels of neurotrophins and pro-neurotrophins have been associated with neurological disorders, illustrating the importance of these molecules in the central nervous system. Furthermore, reports have indicated that viruses can alter the normal levels of neurotrophins by interfering with their signaling pathways. This work discusses the importance of neurotrophins in the central nervous system, their signaling pathways, and how viruses can affect them.
- Open Access
BCG-Based Vaccines Elicit Antigen-Specific Adaptive and Trained Immunity against SARS-CoV-2 and Andes orthohantavirus
Background:Mycobacterium bovis Bacillus Calmette-Guérin (BCG) is a live attenuated vaccine mainly administered to newborns and used for over 100 years to prevent the disease caused by Mycobacterium tuberculosis (M. tb). This vaccine can induce immune response polarization towards a Th1 profile, which is desired for counteracting M. tb, other mycobacteria, and unrelated intracellular pathogens. The vaccine BCG has been used as a vector to express recombinant proteins and has been shown to protect against several diseases, particularly respiratory viruses. Methods: BCG was used to develop recombinant vaccines expressing either the Nucleoprotein from SARS-CoV-2 or Andes orthohantavirus. Mice were immunized with these vaccines with the aim of evaluating the safety and immunogenicity parameters. Results: Immunization with two doses of 1 × 108 CFU or one dose of 1 × 105 CFU of these BCGs was safe in mice. A statistically significant cellular immune response was induced by both formulations, characterized as the activation of CD4+ and CD8+ T cells. Stimulation with unrelated antigens resulted in increased expression of activation markers by T cells and secretion of IL-2 and IFN-γ, while increased secretion of IL-6 was found for both recombinant vaccines; all of these parameters related to a trained immunity profile. The humoral immune response elicited by both vaccines was modest, but further exposure to antigens could increase this response. Conclusions: The BCG vaccine is a promising platform for developing vaccines against different pathogens, inducing a marked antigen-specific immune response.
Open AccessBCG-Based Vaccines Elicit Antigen-Specific Adaptive and Trained Immunity against SARS-CoV-2 and Andes orthohantavirus
Background:Mycobacterium bovis Bacillus Calmette-Guérin (BCG) is a live attenuated vaccine mainly administered to newborns and used for over 100 years to prevent the disease caused by Mycobacterium tuberculosis (M. tb). This vaccine can induce immune response polarization towards a Th1 profile, which is desired for counteracting M. tb, other mycobacteria, and unrelated intracellular pathogens. The vaccine BCG has been used as a vector to express recombinant proteins and has been shown to protect against several diseases, particularly respiratory viruses. Methods: BCG was used to develop recombinant vaccines expressing either the Nucleoprotein from SARS-CoV-2 or Andes orthohantavirus. Mice were immunized with these vaccines with the aim of evaluating the safety and immunogenicity parameters. Results: Immunization with two doses of 1 × 108 CFU or one dose of 1 × 105 CFU of these BCGs was safe in mice. A statistically significant cellular immune response was induced by both formulations, characterized as the activation of CD4+ and CD8+ T cells. Stimulation with unrelated antigens resulted in increased expression of activation markers by T cells and secretion of IL-2 and IFN-γ, while increased secretion of IL-6 was found for both recombinant vaccines; all of these parameters related to a trained immunity profile. The humoral immune response elicited by both vaccines was modest, but further exposure to antigens could increase this response. Conclusions: The BCG vaccine is a promising platform for developing vaccines against different pathogens, inducing a marked antigen-specific immune response.
- Open Access
Potential Neurocognitive Symptoms Due to Respiratory Syncytial Virus Infection
Respiratory infections are among the major public health burdens, especially during winter. Along these lines, the human respiratory syncytial virus (hRSV) is the principal viral agent causing acute lower respiratory tract infections leading to hospitalization. The pulmonary manifestations due to hRSV infection are bronchiolitis and pneumonia, where the population most affected are infants and the elderly. However, recent evidence suggests that hRSV infection can impact the mother and fetus during pregnancy. Studies have indicated that hRSV can infect different cell types from the placenta and even cross the placenta barrier and infect the fetus. In addition, it is known that infections during the gestational period can lead to severe consequences for the development of the fetus due not only to a direct viral infection but also because of maternal immune activation (MIA). Furthermore, it has been described that the development of the central nervous system (CNS) of the fetus can be affected by the inflammatory environment of the uterus caused by viral infections. Increasing evidence supports the notion that hRSV could invade the CNS and infect nervous cells, such as microglia, neurons, and astrocytes, promoting neuroinflammation. Moreover, it has been described that the hRSV infection can provoke neurological manifestations, including cognitive impairment and behavioral alterations. Here, we will review the potential effect of hRSV in brain development and the potential long-term neurological sequelae.
Open AccessPotential Neurocognitive Symptoms Due to Respiratory Syncytial Virus Infection
Respiratory infections are among the major public health burdens, especially during winter. Along these lines, the human respiratory syncytial virus (hRSV) is the principal viral agent causing acute lower respiratory tract infections leading to hospitalization. The pulmonary manifestations due to hRSV infection are bronchiolitis and pneumonia, where the population most affected are infants and the elderly. However, recent evidence suggests that hRSV infection can impact the mother and fetus during pregnancy. Studies have indicated that hRSV can infect different cell types from the placenta and even cross the placenta barrier and infect the fetus. In addition, it is known that infections during the gestational period can lead to severe consequences for the development of the fetus due not only to a direct viral infection but also because of maternal immune activation (MIA). Furthermore, it has been described that the development of the central nervous system (CNS) of the fetus can be affected by the inflammatory environment of the uterus caused by viral infections. Increasing evidence supports the notion that hRSV could invade the CNS and infect nervous cells, such as microglia, neurons, and astrocytes, promoting neuroinflammation. Moreover, it has been described that the hRSV infection can provoke neurological manifestations, including cognitive impairment and behavioral alterations. Here, we will review the potential effect of hRSV in brain development and the potential long-term neurological sequelae.